E2 ModerateModerate confidencePEM ?Cross-SectionalPeer-reviewedMachine draft
Urinary free cortisol in chronic fatigue syndrome.
Cleare, A J, Blair, D, Chambers, S et al. · The American journal of psychiatry · 2001 · DOI
Quick Summary
This study measured a stress hormone called cortisol in the urine of people with ME/CFS and compared it to healthy controls. The researchers found that people with ME/CFS had lower cortisol levels than expected. This difference was consistent across the patient group and wasn't explained by depression, medications, sleep problems, or disability levels.
Why It Matters
This finding suggests that ME/CFS may involve dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, a system crucial for stress response and immune regulation. Identifying biological markers like abnormal cortisol levels could help validate ME/CFS as a physiological condition and potentially guide future treatment approaches targeting endocrine dysfunction.
Observed Findings
- Urinary free cortisol was significantly lower in ME/CFS patients compared to comparison subjects
- Lower cortisol levels were present in ME/CFS patients regardless of comorbid psychiatric illness
- Cortisol abnormalities were independent of medication use
- Cortisol levels did not correlate with sleep disturbance or disability severity
Inferred Conclusions
- Mild hypocortisolism is present in ME/CFS
- Hypocortisolism may contribute to ME/CFS symptoms
- The HPA axis dysfunction appears to be a consistent feature of ME/CFS not explained by psychiatric comorbidity
Remaining Questions
- Is the hypocortisolism a primary pathological feature of ME/CFS or secondary to other biological abnormalities?
- Does cortisol dysregulation worsen or improve with disease progression or recovery?
- Could cortisol-based treatments or HPA axis support alleviate ME/CFS symptoms?
- How does this hypocortisolism relate to immune dysfunction and other biomarkers in ME/CFS?
What This Study Does Not Prove
This study does not prove that low cortisol causes ME/CFS or is the primary mechanism of the illness. The cross-sectional design captures one moment in time and cannot establish whether cortisol abnormalities develop before, during, or as a consequence of illness. It does not identify whether hypocortisolism is a direct feature of ME/CFS pathology or secondary to other biological processes.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:PEM Not DefinedWeak Case Definition